Program

 

7:30 - 8:00

Registration

8:00 - 8:15

 

 

 

Welcome

Naglaa Shoukry, PhD

Professor, Department of Medicine, Université de Montréal and CRCHUM, Montreal, QC

Director, Canadian Network on Hepatitis C

SESSION I

Session Chairs:  Drs. Naglaa Shoukry & Pascal Lapierre

8:15 – 8:45

 

 

 

Human B cell responses to influenza virus: Issues of specificity, affinity and memory

Ali Ellebedy, PhD

Assistant Professor

Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO

8:45 – 9:15

 

 

 

 

 

Role of type I interferon in the impairment of humoral immune responses during persistent viral infection

Alain Lamarre, PhD

Professor and Head, Immunovirology Laboratory,

Jeanne and J.-Louis Lévesque Research Chair in Immunovirology,

INRS-Institut Armand-Frappier, Laval, QC

9:15 – 9:45

 

 

 

 

 

Host-pathogen interactions during mother-to-child transmission of HCV and HIV-1

Hugo Soudeyns, PhD

Professor and Director, Unité d’immunopathologie virale, Centre de recherche du CHU Sainte-Justine,

Departments of Microbiology, Infectiology & Immunology and Pediatrics, Faculty of Medicine, Université de Montréal, Montreal, QC

9:45 – 10:15

 

Coffee Break

 

10:15 – 10:30

 

 

10:30 – 10:45

 

 

A novel platform for analysis of antigen-specific B cells from HCV-infected patients

Eduardo Salinas Duron, PhD, Emory University

 

Tfh and B cell responses during acute HCV infection

Maude Boisvert, PhD, CRCHUM

                                                                    

10:45 – 11:30

 

 

 

B cell responses to influenza: Translating basic science

Patrick C. Wilson, PhD

Professor

Department of Medicine, University of Chicago, Chicago, USA

11:30 – 12:00

Break

12:00 - 12:45

 

 

 

Host-driven alterations in gut microbiota and intrahepatic immune pathology

Arash Grakoui, PhD

Associate Professor

Emory University School of Medicine, Atlanta, GA

12:45 – 14:15

Lunch

SESSION II

Session Chairs:  Drs. Hugo Soudeyns & Alain Lamarre

14:15 – 14:45

 

 

 

Role of T vs B cells in long-term protective immunity against HCV

Naglaa Shoukry, PhD

Professor, Department of Medicine, Université de Montréal and CRCHUM, Montreal, QC

Director, Canadian Network on Hepatitis C

14:45 – 15:30

 

 

 

 

 

New developments for use of interferon and other immune modulators in HBV therapy

Harry Janssen, MD, PhD

Professor of Medicine and Francis Family Chair in Hepatology, University of Toronto, Toronto, ON

Director, Toronto Centre for Liver Disease

15:30 – 16:00

Coffee Break

16:00 – 16:45

 

 

 

 

CD8 T cells and immune restoration following antiviral therapy

Robert Thimme, MD

Professor of Hepatology, Medical Director

Medical Center – University of Freiburg

Department of Medicine II

16:45 – 17:45

Panel Discussion